SCM
BDSX icon

Silverarc Capital Management’s Biodesix BDSX Stock Holding History

Silverarc Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,607
Closed -$375K – 73
2025
Q3 		$375K Sell
49,607
-3,911
-7% -$30.1K 0.05% 76
2025
Q2 		$302K Sell
53,518
-151,402
-74% -$1.22M 0.06% 60
2025
Q1 		$2.56M Sell
204,920
-11,694
-5% -$224K 0.52% 48
2024
Q4 		$6.63M Buy
216,614
+38,559
+22% +$1.13M 1.45% 26
2024
Q3 		$6.34M Buy
178,055
+87,607
+97% +$3.01M 1.42% 24
2024
Q2 		$2.77M Buy
+90,448
New +$2.58M 0.65% 39

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Silverarc Capital Management's BDSX Position: Q4 2025 in Review

Silverarc Capital Management sold out of Biodesix (BDSX) in Q4 2025, closing a stake of 49,607 shares — an estimated $375K sold.

Silverarc Capital Management first reported a position in BDSX in Q2 2024 and held it in 6 quarters. The position peaked at $6.63M in Q4 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q4 2025.

  • Silverarc Capital Management reported no remaining Biodesix position as of Q4 2025 after selling out during the quarter.
  • Silverarc Capital Management sold 49,607 Biodesix shares in Q4 2025, an estimated $375K.
  • Silverarc Capital Management first reported a position in Biodesix in Q2 2024 and held it in 6 quarters.
  • Silverarc Capital Management's Biodesix position peaked at $6.63M in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q4 2025.

Based on Silverarc Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.